# Filing Detail

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-25-079602
Filing Date
2025-08-22
Accepted
2025-08-22 09:16:10
Documents
6
Period of Report
2025-08-22

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | REPORT OF FOREIGN PRIVATE ISSUER | ea0254212-6k_akanda.htm | 6-K | 10522
2 | PRESS RELEASE, DATED AUGUST 22, 2025, ANNOUNCING SHARE CONSOLIDATION | ea025421201ex99-1_akanda.htm | EX-99.1 | 12201
3 | ARTICLES AND CERTIFICATE OF AMENDMENT OF AKANDA CORP | ea025421201ex99-2_akanda.htm | EX-99.2 | 2330
4 | GRAPHIC | ex99-2_001.jpg | GRAPHIC | 501915
5 | GRAPHIC | ex99-2_002.jpg | GRAPHIC | 564824
6 | GRAPHIC | ex99-2_003.jpg | GRAPHIC | 182934
| Complete submission text file | 0001213900-25-079602.txt |  | 1745293

Mailing Address 77 KING STREET WEST, SUITE 400 C/O DENTONS CANADA LLP TORONTO A6 M5K 0A1
Business Address 1A, 1B LEAROYD ROAD NEW ROMNEY X0 TN28 8XU 442034889514
AKANDA CORP. (Filer) CIK: 0001888014 (see all company filings)

EIN.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-41324 | Film No.: 251242452
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)